HMGA2 and metastatic malignant neoplasm in the lymph nodes: Out of the 444 samples, HMGA2 amplification is observed in 4 samples in bone metastasis and 11 samples in lymph node metastasis, which comes to a percentage of 2.5% HMGA2 amplification in bone and lymph node metastasis (Figure 6A, link).